Grant Street Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Grant Street Asset Management's GILD Position: Q2 2021 in Review
Grant Street Asset Management sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 909 shares — an estimated $59K sold.
Grant Street Asset Management first reported a position in GILD in Q4 2020 and held it in 2 quarters. The position peaked at $59K in Q1 2021. 1,545 funds tracked by Wall St. Rank hold GILD as of Q2 2021.
- Grant Street Asset Management reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
- Grant Street Asset Management sold 909 Gilead Sciences shares in Q2 2021, an estimated $59K.
- Grant Street Asset Management first reported a position in Gilead Sciences in Q4 2020 and held it in 2 quarters.
- Grant Street Asset Management's Gilead Sciences position peaked at $59K in Q1 2021.
- 1,545 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.
Based on Grant Street Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.